You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VERA Sale Disclosure
Fordyce Marshall · SEC Form 4 · Filed Aug 12, 2026
Sale
Calculated transaction value
$1.37M
Fordyce Marshall President And CEO
VERA
Vera Therapeutics
VERA
Transaction date
Jul 7, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 36 days later
VERA daily price context
Close on/before transaction
$42.96
Jul 7, 2026
First close after public filing
$28.89
Aug 13, 2026
30-day return after filing
+21.32%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 32,550 shares @ $42.07
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4/A
- Filing identifier
- 0001859453-26-000013
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$2.09M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vera Therapeutics, Inc. VERA | Sale | Jul 7, 2026 | $40.78K |
| Vera Therapeutics, Inc. VERA Current | Sale | Jul 7, 2026 | $1.37M |
| Vera Therapeutics, Inc. VERA | Sale | Jul 7, 2026 | $450.01K |
| Vera Therapeutics, Inc. VERA | Sale | Jul 7, 2026 | $95.91K |
| Vera Therapeutics, Inc. VERA | Exercise | Jul 7, 2026 | $0 |
| Vera Therapeutics, Inc. VERA | Exercise | Jul 7, 2026 | $133.98K |